[1]
2026. Therapeutic Strategy and Resistance Mechanism of PD-L1 Monoclonal Antibody in Precision Population of Gastric Cancer. Highlights in Science, Engineering and Technology. 162, (Apr. 2026), 308–313. DOI:https://doi.org/10.54097/qvx7x114.